Core Viewpoint - Investors are seeking growth stocks that can deliver above-average growth and exceptional returns, but identifying such stocks can be challenging due to inherent risks and volatility [1] Group 1: Growth Stock Identification - The Zacks Growth Style Score system helps identify promising growth stocks by analyzing real growth prospects beyond traditional metrics [2] - The Pennant Group, Inc. (PNTG) is highlighted as a recommended stock with a favorable Growth Score and a top Zacks Rank [2] Group 2: Earnings Growth - Earnings growth is a critical factor for growth investors, with double-digit growth seen as a strong indicator of future stock price gains [3] - The Pennant Group's projected EPS growth for this year is 23.7%, significantly higher than the industry average of 14.1% [4] Group 3: Asset Utilization - The asset utilization ratio, or sales-to-total-assets (S/TA) ratio, is an important metric for assessing a company's efficiency in generating sales [5] - The Pennant Group has an S/TA ratio of 1.09, outperforming the industry average of 0.82, indicating better efficiency [6] Group 4: Sales Growth - The Pennant Group's sales are expected to grow by 24.4% this year, compared to the industry average of 6.3%, showcasing strong sales growth potential [6] Group 5: Earnings Estimate Revisions - Positive trends in earnings estimate revisions correlate strongly with stock price movements, and The Pennant Group has seen upward revisions in current-year earnings estimates [7] - The Zacks Consensus Estimate for the current year has increased by 1.4% over the past month for The Pennant Group [7] Group 6: Overall Assessment - The Pennant Group has achieved a Growth Score of B and a Zacks Rank 2 due to positive earnings estimate revisions, indicating it is a solid choice for growth investors [8]

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. However, it isn't easy to find a great growth stock. That's because, these stocks usually carry above-average risk and volatility. In fact, betting on a stock for which the growth story is actually over or nearing its end could lead to significant loss. However, the Zacks Growth Style Score (part of the Zacks Style Scores system), which look ...

Financial Data and Key Metrics Changes - The company reported Q2 2024 revenue of $168.7 million, an increase of $36.4 million or 27.6% year-over-year, with adjusted EBITDA of $13.2 million and adjusted earnings per share of $0.24, exceeding consensus estimates [6][22][24] - Full year revenue guidance was raised to a range of $654 million to $694.5 million, representing a 5.7% increase over the original guidance and a 61.4% increase over 2022 adjusted earnings [8][23] Business Line Data and Key Metrics Changes - Home Health and Hospice segment revenue reached $125.3 million, up $30.3 million or 31.9% year-over-year, with adjusted EBITDA of $19.6 million, an increase of 36.3% [10] - Hospice revenue was $59.3 million, a 27.5% increase, with admissions rising 31.4% and average daily census increasing 29.1% [11] - Home Health revenue grew to $66 million, a 36.1% increase, with total admissions up 35.4% and Medicare admissions up 18.3% [12] - Senior Living segment revenue improved to $43.4 million, a 16.6% increase, with same-store occupancy at 79.2% [17] Market Data and Key Metrics Changes - The company added over 2,200 lives through acquisitions and organic growth, representing a greater than 50% increase compared to the end of 2023 [7] - The management agreement with Hartford HealthCare is expected to enhance the company's presence and operational capabilities in the East Coast market [19][20] Company Strategy and Development Direction - The company is focused on leadership development, clinical excellence, employee engagement, margin improvement, and growth as key strategic areas [5][6] - The decentralized acquisition model allows local leaders to make decisions, facilitating growth while transitioning new operations [18] - The acquisition of Signature Healthcare at Home is strategically important for expanding the company's footprint in the Pacific Northwest [21][22] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the company's growth trajectory, citing strong performance across all business lines and a healthy balance sheet [9][23] - The company anticipates continued strong operating performance and is prepared to address challenges in the reimbursement environment [16][42] Other Important Information - The company has increased its borrowing capacity to $250 million, enhancing its financial flexibility for future growth [8][24] - The average CMS star rating for the company is 4.1, significantly above the national average of 3.0, indicating strong clinical quality [13] Q&A Session Summary Question: Context on Signature integration timeline and key milestones - Management highlighted the focus on integrating leadership and systems for the first phase of the Signature acquisition, with further integration planned for the Oregon assets in early 2025 [30][31] Question: Revenue and EBITDA split between Signature tranches - The revenue split is approximately 2/3 for Oregon and 1/3 for Washington, with expectations for higher margins from the Oregon portion due to its hospice component [34][36] Question: Breakdown of revised guidance contributions from business lines - Hospice and Home Health segments showed significant growth, with hospice admissions up 30% and Home Health admissions nearly 30%, contributing to the guidance raise [39][40] Question: Leverage ratio expectations post-acquisition - The leverage ratio is expected to be between 2 to 2.5x at the beginning of 2025, with a plan to reduce it to under 2x as strong cash flow is anticipated [45]

For the quarter ended June 2024, The Pennant Group, Inc. (PNTG) reported revenue of $168.75 million, up 27.6% over the same period last year. EPS came in at $0.24, compared to $0.18 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $156.71 million, representing a surprise of +7.68%. The company delivered an EPS surprise of +14.29%, with the consensus EPS estimate being $0.21. While investors scrutinize revenue and earnings changes year-over-year and how they compare w ...

The Pennant Group, Inc. (PNTG) came out with quarterly earnings of $0.24 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.18 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 14.29%. A quarter ago, it was expected that this company would post earnings of $0.18 per share when it actually produced earnings of $0.20, delivering a surprise of 11.11%. Over the last four quarters, th ...

EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ:PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it has completed its purchase of the Washington and Idaho assets of Signature Healthcare at Home. Pennant previously announced its agreement to purchase the Signature assets, with the planned closing of Signature's Washington and Idaho assets on August 1, and a second purchase agreement capturing Si ...

EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that the Company has increased its credit facility by $100 million to an aggregate of $250 million. The borrowings are supported by a lending consortium arranged by Truist Securities. The new facility expires on July 31, 2029. "This amended facility further strengthens our balance sheet, and together wi ...

EAGLE, Idaho, Aug. 01, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, today announced that the Company has increased its credit facility by $100 million to an aggregate of $250 million. The borrowings are supported by a lending consortium arranged by Truist Securities. The new facility expires on July 31, 2029. "This amended facility further strengthens our balance sheet, and together wi ...

To listen to the webcast, or to view any financial or other statistical information required by SEC Regulation G, please visit the Investor Relations section of our website at http://investor.pennantgroup.com. The webcast will be recorded and will be available for replay via the website until 5:00 p.m. Mountain Time on August 6, 2025. The Pennant Group, Inc. is a holding company of independent operating subsidiaries that provide healthcare services through 118 home health and hospice agencies and 54 senior ...

EAGLE, Idaho, July 23, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of operating subsidiaries that provide home health, hospice and senior living services, announced today that it expects to issue its second quarter 2024 financial results on Tuesday, August 6, 2024. Pennant invites current and prospective investors to tune into a live webcast to be held the following day, Wednesday, August 7, 2024, at 10:00 a.m. Mountain Time (12:00 p.m. Eastern Time), during which Pen ...